Ginsenoside Rb1 alleviates chronic intermittent hypoxia-induced diabetic cardiomyopathy in db/db mice by regulating the adenosine monophosphate-activated protein kinase/Nrf2/heme oxygenase-1 signaling pathway
CONCLUSION: Rb1 treatment alleviated CIH-induced diabetic cardiomyopathy and glycolipid metabolism disorders in db/db mice by inhibiting oxidative stress and regulating the AMPK/Nrf2/HO-1 signaling pathway.PMID:37679978 | PMC:PMC10465847 | DOI:10.19852/j.cnki.jtcm.20221206.004
Source: Journal of Traditional Chinese Medicine - Category: Complementary Medicine Authors: Liu Bingbing L I Jieru S I Jianchao Chen Qi Yang Shengchang J I Ensheng Source Type: research
More News: Cardiology | Cardiomyopathy | China Health | Cholesterol | Complementary Medicine | Diabetes | Endocrinology | Heart | Insulin | Pathology